DIANA BAN: Open Payments
NPI 1649881178 · KNIGHTDALE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$251 in 14 payments from 6 companies in 2025. Trend: 2023 $209 · 2024 $320 · 2025 $251
Food & beverage: $251
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $91 |
| ABBVIE INC. | 2 | $35 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| PFIZER INC. | 2 | $34 |
| Lilly USA, LLC | 2 | $34 |
| Boston Scientific Corporation | 1 | $22 |
Products named: Wegovy, Ozempic, VRAYLAR, PREVNAR 20, MOUNJARO, WaveWriter Alpha Prime 16, AIRSUPRA, FARXIGA.
Industry payments across NC — which companies pay providers there.
